Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2005
12/29/2005US20050288337 Novel compounds
12/29/2005US20050288324 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
12/29/2005US20050288323 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine
12/29/2005US20050288322 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide
12/29/2005US20050288321 Alzheimer's disease ; 3-(2,3-dihydro-5,6-difluorobenzofur-7-yl)-4-[1-(piperidin-4-yl)-1H-indol-3-yl]pyrrole-2,5-dione; stimulating bone deposition
12/29/2005US20050288313 Synergistically combined with immunomodulators or antiinflammtory agents; treating rheumatoid arthritis; inhibiting organ transplant rejection; Janus Kinase 3 inhibitors such as CP 690550, 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
12/29/2005US20050288312 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
12/29/2005US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives
12/29/2005US20050288303 Cyclic protein tyrosine kinase inhibitors
12/29/2005US20050288296 2,3-Dimethylindolo[2,3-b]quinoxaline-6-yl-acetamide; 9-Chloro-2,3-dimethyl-6-(aminoethylamino-2-oxoethyl)-6H-indolo[2,3-b]quinoxaline; autoimmune diseases
12/29/2005US20050288293 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
12/29/2005US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/29/2005US20050288276 Pharmaceutical formulation of olanzapine
12/29/2005US20050288262 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
12/29/2005US20050288254 Treating sepsis or septic shock by administering 1-stearoyl, 1-palmitoyl-, 1-myristoyl- lysophosphatidylcholine, or 1-oleoyllysophosphatidylcholine or sphingosylphosphorylcholine.
12/29/2005US20050288249 Testing a compound for the ability to inhibit PKG I alpha; testing the compound for the ability to inhibit PKG I beta; identifying the compound as a candidate drug useful in the treatment of pain ifit selectively inhibits PKG I alpha relative to PKG I beta .
12/29/2005US20050288231 Biologically active peptides as glutamate receptor inhibitors
12/29/2005US20050288222 Methods for enhancing the bioavailability of a drug
12/29/2005US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/29/2005US20050287605 Caspase 3 inhibitors
12/29/2005US20050287546 Novel proteases
12/29/2005US20050287529 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof
12/29/2005US20050287168 Recombinant spores
12/29/2005US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis
12/29/2005DE102005027905A1 Combating stress states or nervous system or metabolic disorders, using glycine as neurotransmission modulator showing antistress, stress protective, nootropic and toxin binding actions
12/29/2005DE102004027912A1 Substituierte Cyclopenten-Verbindungen Substituted cyclopentene compounds
12/29/2005DE102004027359A1 Pyridin-2-onverbindungen und deren Verwendung Pyridin-2-one compounds and use thereof
12/29/2005DE102004027358A1 Pyrimidinverbindungen und ihre Verwendung Pyrimidine compounds and their use
12/29/2005DE102004025726A1 Verwendung eines spezifischen K252a-Derivats für die Behandlung von neurodegenerativen Erkrankungen, die durch eine pathologische Hyperphosphorylierung und eine Aggregation von Tau Proteinen in neurofibrillären Knäueln charakterisiert sind Using a specific K252a derivative for the treatment of neurodegenerative diseases, which are characterized by a pathological hyperphosphorylation of tau protein and aggregation in neurofibrillary tangles
12/29/2005CA2612146A1 Treating cancer
12/29/2005CA2571487A1 Pyrrazolo-pyrimidine derivatives
12/29/2005CA2570267A1 Fgfr binding peptides
12/29/2005CA2570130A1 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
12/29/2005CA2570075A1 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/29/2005CA2570065A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors
12/29/2005CA2570064A1 Novel alkyl substituted piperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/29/2005CA2566155A1 1-aza-bicyclo[3.3.1]nonanes
12/28/2005EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP)
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609856A2 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
12/28/2005EP1609803A1 Modified antibody against cd22 and utilization thereof
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
12/28/2005EP1609505A1 Uses of fluorinated triazoles for treaing pain and affective or attention disorders
12/28/2005EP1609480A1 Remedy for spinal canal stenosis
12/28/2005EP1608654A2 8-SUBSTITUTED-6, 7, 8,9-TETRAHY9DROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
12/28/2005EP1608653A1 SUBSTITUTED 8-PERFLUOROALKYL-6,7,8,9-TETRAHYDROPYRIMIDO (1,2- a) PYRIMIDIN-4-ONE DERIVATIVES
12/28/2005EP1608648A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
12/28/2005EP1608638A1 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
12/28/2005EP1608635A1 Phenyl sulfone derivatives and their use in the treatment of cns disorders
12/28/2005EP1608630A1 2, 3, 6-trisubstituted-4-pyrimidone derivatives
12/28/2005EP1608625A1 Acutumine and acutumine compounds, synthesis and use
12/28/2005EP1608619A1 Muscarinic agonists
12/28/2005EP1608617A1 Muscarinic agonists
12/28/2005EP1608372A2 Compositions containing fentanyl
12/28/2005EP1608361A2 Compositions of cyclooxygenase-2 selective inhibitors and 5-ht1b/1d agonists for the treatment and prevention of migraine
12/28/2005EP1608355A2 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases
12/28/2005EP1608354A1 Compounds having serotonin 5-ht7 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders
12/28/2005EP1608350A1 Methods of preventing, treating and diagnosing disorders of protein aggregation
12/28/2005EP1608315A2 Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor
12/28/2005EP1497288B1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
12/28/2005EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
12/28/2005EP1461318B9 Tetrahydroquinoline analogues as muscarinic agonists
12/28/2005EP1389208B1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1368023B1 Utilization of buprenorphine in urinary incontinence therapy
12/28/2005EP1332138B1 Radiopharmaceuticals for diagnosing alzheimer's disease
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005EP1254131B8 Extraction of flavonoids
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
12/28/2005EP1218023B1 Method for calming human beings using personal care compositions
12/28/2005EP1161418B1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
12/28/2005EP1156811B1 Copper agonist that binds on the copper binding site of amyloid precursor protein (app) and/or exerts an inhibiting effect on the release of amyloid-beta-peptide
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/28/2005EP1066033B1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
12/28/2005EP1053238B1 Therapeutic compounds
12/28/2005EP1024802B1 Cannabinol-11-oic acid derivatives useful as antiinflammatory agents and analgesics
12/28/2005EP0971959B1 Humanized antibodies and methods for forming humanized antibodies
12/28/2005EP0920448B1 Truncated glial cell line-derived neurotrophic factor
12/28/2005EP0859840B1 Biologically active eph family ligands
12/28/2005EP0778836B1 Substituted 9-alkyladenines
12/28/2005CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
12/28/2005CN1714096A Mmp inhibitors
12/28/2005CN1714093A Diazinopyrimidines
12/28/2005CN1714089A Novel use of substituted aminomethyl chromans
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1714082A Process for preparation of imidazolyl compounds
12/28/2005CN1714081A Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
12/28/2005CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy.
12/28/2005CN1713909A Aminoindazole derivatives and use thereof as kinase inhibitors
12/28/2005CN1713908A Aminoalkoxyindoles as 5-HT6-receptor ligands for the treatment of CNA-disorders
12/28/2005CN1713900A Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
12/28/2005CN1233649C Compound Bajisu A and its preparation and use
12/28/2005CN1233645C Novel oripavine derivative and its medical use
12/28/2005CN1233643C Ramification of a compound of medication as well as preparation method and application
12/28/2005CN1233629C Sulfolipid compound with neural nourishing function and synthetic method and application thereof
12/28/2005CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
12/28/2005CN1233401C Agastache capsule for restoring healthy energy and its preparation
1 ... 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 ... 1833